These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6330853)

  • 41. Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.
    Zhaori G; Sun M; Ogra PL
    J Infect Dis; 1988 Jul; 158(1):160-5. PubMed ID: 2839578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Wiebe RA
    JAMA; 1978 May; 239(21):2252-5. PubMed ID: 206735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of neutralizing antibody responses against poliovirus types 1, 2 and 3 in the Tripoli area of the Socialist People's Libyan Arab Jamahiriya.
    el Nageh M; Khadre MA; Gould EA
    Trans R Soc Trop Med Hyg; 1988; 82(5):758-60. PubMed ID: 2855283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody levels against polioviruses in children following Pulse Polio Immunization Program.
    Hasan AS; Malik A; Shukla I; Malik MA
    Indian Pediatr; 2004 Oct; 41(10):1040-4. PubMed ID: 15523131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
    Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
    Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
    Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
    Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of poliovirus antigens and antibodies: microindirect haemagglutination and haemagglutination inhibition tests for poliovirus types I, II, and III.
    Esposito JJ
    Microbios; 1976; 16(63):29-36. PubMed ID: 194134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
    Lamy ME; Cornu C; Desmyter J
    Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.
    Manukyan H; Petrovskaya S; Chumakov K; Laassri M
    Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32150852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of serum neutralizing antibody against poliovirus in patients with juvenile distal spinal muscular atrophy of upper extremities.
    Kao KP; Liu WT; Wang SJ; Chern CM
    Brain Dev; 1993; 15(3):219-21. PubMed ID: 8214348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil.
    Luchs A; Cilli A; Russo DH; Costa FF; Carmona Rde C; Timenetsky Mdo C
    Trans R Soc Trop Med Hyg; 2010 Sep; 104(9):625-7. PubMed ID: 20708125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of neutralizing antibodies by all three structural poliovirus polypeptides.
    Dernick R; Heukeshoven J; Hilbrig M
    Virology; 1983 Oct; 130(1):243-6. PubMed ID: 6314647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 60. [Third oral polio immunization--what is the good of it?].
    Haas R; Petersen EE; Neumann-Haefelin D; Schnetter C
    Dtsch Med Wochenschr; 1973 Mar; 98(10):476-9. PubMed ID: 4348024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.